Hi-Tech Pharmacal Co., Inc. HITK announced today the signing of a definitive agreement under which Hi-Tech acquired several homeopathic branded nasal spray products including Sinus Buster® and Allergy Buster® from Dynova Laboratories, Inc. for $1.25 million in cash and an additional $1.25 million deposited in an escrow account to pay for certain expenses. Hi-Tech will also pay a royalty on Net Sales for 3 ½ years, or $1.75 million, whichever is reached first. The product line had Net Sales of $3.3 million in 2011. The brands will be sold through the Company's Health Care Products OTC division.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in